CAT-3888 (BL22), another immunotoxin, which targets the CD22 antigen on certain lymphoma cells, attached to a bacterial Pseudomonas exotoxin, PE38, has shown activity against hairy cell leukemia (HCL) in early clinical trials (25). The gene discussed is CD22; the disease is hairy cell leukemia.